Eli Lilly (LLY) revised its revenue outlook on Tuesday for the fourth quarter of 2024 on weaker-than-expected demand for its popular weight-loss drugs, Zepbound and Mounjaro.
Read more...
Hence then, the article about eli lilly was hoping for even greater weight loss drug demand was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Eli Lilly was hoping for even greater weight loss drug demand )
Last updated :
Also on site :
- What is economic abuse? Expert explains controlling relationship trend and how to get help
- ASPIRE-Lowell: A Unique Experiment and a Generous Gift for Promoting Hands-on STEM Learning in Lowell Public Schools
- Best children’s savings accounts for 2026 - where to find the top interest rates